US2007202200A1PendingUtilityA1

Method of inhibiting weight regain after weight loss

59
Individually held — no corporate assignee on recordPriority: Apr 21, 2005Filed: May 1, 2007Published: Aug 30, 2007
Est. expiryApr 21, 2025(expired)· nominal 20-yr term from priority
Inventors:Arne AstrupSoren Toubro
A61K 36/82A61K 31/522A61K 33/06B33Y 80/00A61P 3/04A61K 31/198
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental caffeine and/or and analogs thereof, green tea extract containing catechin and caffeine, and embodiments which include calcium. The invention is also directed toward methods for reducing and maintaining weight of a human using the composition.

Claims

exact text as granted — not AI-modified
1 . A method for inhibiting weight regain after a desired weight loss comprising the step of administrating an effective amount of a composition comprising capsaicin or an analog thereof, L-tyrosine, green tea extract, and supplemental caffeine or an analog thereof.  
   
   
       2 . The method of  claim 1 , wherein the green tea extract comprises catechin and caffeine.  
   
   
       3 . The method of  claim 1 , wherein the green tea extract comprises about 31 to about 1,500 mg by weight of catechin and about 12 to about 600 mg by weight of caffeine.  
   
   
       4 . The method of  claim 1 , wherein the composition comprises about 0.1 to about 4.8 mg by weight of capsaicin or an analog thereof; about 101 to about 4,800 mg by weight of L-tyrosine; about 125 to about 6,000 mg by weight of the green tea extract; and about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       5 . The method of  claim 1 , wherein the composition comprises about 10,000 to about 480,000 Scoville heat units by weight of capsaicin or an analog thereof, about 101 to about 4,800 mg by weight of L-tyrosine; about 125 to about 6,000 mg by weight of the green tea extract; and about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       6 . The method of  claim 1 , wherein the composition comprises about 0.1 to about 4.8 mg by weight of capsaicin or an analog thereof.  
   
   
       7 . The method of  claim 1 , wherein the composition comprises about 10,000 to about 480,000 Scoville heat units by weight of capsaicin or an analog thereof.  
   
   
       8 . The method of  claim 1 , wherein the composition comprises about 101 to about 4,800 mg by weight of L-tyrosine.  
   
   
       9 . The method of  claim 1 , wherein the composition comprises about 125 to about 6,000 mg by weight of the green tea extract.  
   
   
       10 . The method of  claim 1 , wherein the composition comprises about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       11 . The method of  claim 1 , wherein the composition further comprises calcium.  
   
   
       12 . The method of  claim 11 , wherein the composition comprises about 50 to about 8,000 mg by weight of calcium.  
   
   
       13 . The method of  claim 1 , wherein the composition further comprises a pharmaceutically acceptable carrier.  
   
   
       14 . A method for inhibiting body fat mass regain after a desired body fat mass loss comprising the step of administrating an effective amount of a composition comprising capsaicin or an analog thereof, L-tyrosine, green tea extract, and supplemental caffeine or an analog thereof.  
   
   
       15 . The method of  claim 14 , wherein the green tea extract comprises catechin and caffeine.  
   
   
       16 . The method of  claim 14 , wherein the green tea extract comprises about 31 to about 1,500 mg by weight of catechin and about 12 to about 600 mg by weight of caffeine.  
   
   
       17 . The method of  claim 14 , wherein the composition comprises about 0.1 to about 4.8 mg by weight of capsaicin or an analog thereof; about 101 to about 4,800 mg by weight of L-tyrosine; about 125 to about 6,000 mg by weight of the green tea extract; and about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       18 . The method of  claim 14 , wherein the composition comprises about 10,000 to about 480,000 Scoville heat units by weight of capsaicin or an analog thereof; about 101 to about 4,800 mg by weight of L-tyrosine; about 125 to about 6,000 mg by weight of the green tea extract; and about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       19 . The method of  claim 14 , wherein the composition comprises about 0.1 to about 4.8 mg by weight of capsaicin or an analog thereof.  
   
   
       20 . The method of  claim 14 , wherein the composition comprises about 10,000 to about 480,000 Scoville heat units by weight of capsaicin or an analog thereof.  
   
   
       21 . The method of  claim 14 , wherein the composition comprises about 101 to about 4,800 mg by weight of L-tyrosine.  
   
   
       22 . The method of  claim 14 , wherein the composition comprises about 125 to about 6,000 mg by weight of the green tea extract.  
   
   
       23 . The method of  claim 14 , wherein the composition comprises about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       24 . The method of  claim 14 , wherein the composition further comprises calcium.  
   
   
       25 . The method of  claim 24 , wherein the composition comprises about 50 to about 8,000 mg by weight of calcium.  
   
   
       26 . The method of  claim 14 , wherein the composition further comprises a pharmaceutically acceptable carrier.  
   
   
       27 . A method for inhibiting body fat mass regain after a desired weight loss comprising the step of administrating an effective amount of a composition comprising capsaicin or an analog thereof, L-tyrosine, green tea extract, and supplemental caffeine or an analog thereof.  
   
   
       28 . The method of  claim 27 , wherein the green tea extract comprises catechin and caffeine.  
   
   
       29 . The method of  claim 27 , wherein the green tea extract comprises about 31 to about 1,500 mg by weight of catechin and about 12 to about 600 mg by weight of caffeine.  
   
   
       30 . The method of  claim 27 , wherein the composition comprises about 0.1 to about 4.8 mg by weight of capsaicin or an analog thereof; about 101 to about 4,800 mg by weight of L-tyrosine; about 125 to about 6,000 mg by weight of the green tea extract; and about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       31 . The method of  claim 27 , wherein the composition comprises about 10,000 to about 480,000 Scoville heat units by weight of capsaicin or an analog thereof; about 101 to about 4,800 mg by weight of L-tyrosine; about 125 to about 6,000 mg by weight of the green tea extract; and about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       32 . The method of  claim 27 , wherein the composition comprises about 0.1 to about 4.8 mg by weight of capsaicin or an analog thereof.  
   
   
       33 . The method of  claim 27 , wherein the composition comprises about 10,000 to about 480,000 Scoville heat units by weight of capsaicin or an analog thereof.  
   
   
       34 . The method of  claim 27 , wherein the composition comprises about 101 to about 4,800 mg by weight of L-tyrosine.  
   
   
       35 . The method of  claim 27 , wherein the composition comprises about 125 to about 6,000 mg by weight of the green tea extract.  
   
   
       36 . The method of  claim 27 , wherein the composition comprises about 12 to about 600 mg by weight of the supplemental caffeine or an analog thereof.  
   
   
       37 . The method of  claim 27 , wherein the composition further comprises calcium.  
   
   
       38 . The method of  claim 37 , wherein the composition comprises about 50 to about 8,000 mg by weight of calcium.  
   
   
       39 . The method of  claim 27 , wherein the composition further comprises a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2007202200A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.